Research Journal.
In-depth analysis of peptide science, mechanisms of action, and the latest in compound research.
⚠ For research purposes only — not medical advice
BPC-157: The Gastric Peptide Rewriting Tissue Repair Science
Originally isolated from human gastric juice, this 15-amino-acid pentadecapeptide has become a focal point for researchers investigating tissue repair pathways, angiogenesis, and inflammatory signaling.
GHK-Cu: Four Decades of Copper Peptide Science and What Researchers Are Finding
First isolated from human plasma in the 1970s, this copper-binding tripeptide has accumulated over four decades of research across wound healing, collagen synthesis, and gene expression modulation.
Triple Agonism: The Science Behind GLP-1, GIP, and Glucagon Receptor Research
Triple-agonist peptides — compounds designed to simultaneously activate GLP-1, GIP, and glucagon receptors — have emerged as a subject of intense scientific interest in metabolic research.
Wolverine Blend: Faster Recovery and Better Mobility
Why researchers pair BPC-157 and TB-500 — the targeted and systemic peptides commonly explored together for tissue repair, mobility, and full-body recovery.
Retatrutide and Body Composition: How Is GLP-3 Different?
Retatrutide, often called GLP-3, targets GLP-1, GIP, and glucagon receptors simultaneously. Researchers are exploring how this triple agonist design may influence fat mass, lean tissue, and energy expenditure beyond simple weight loss metrics.
Stay Current on Peptide Research
Research updates, compound overviews, and industry literature — delivered monthly. No spam. Research-focused content only.